Merrimack Pharmaceuticals Aktie

Watchlist MACK WKN A2DW3Q ISIN US5903282094

Was macht Merrimack Pharmaceuticals?

Unternehmensprofil
Unternehmensprofil

Merrimack Pharmaceuticals discovers, designs, and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer. Their systems biology is to apply capabilities to build functional and predictive computational models of biological systems such as cell signaling networks.

Chart der Merrimack Pharmaceuticals Aktie

Charttool öffnen

Aktuelle Nachrichten zu Merrimack Pharmaceuticals

Das berichten andere über Merrimack Pharmaceuticals